Business

The Readout Elaine Chen

STAT Plus: Kelonia Therapeutics’ road from floundering to $3 billion

Health Care Inc. Newsletter Bob Herman

STAT Plus: The PBMs fight back, and arbitration doesn’t lose

The Readout Meghana Keshavan

STAT Plus: Finally cracking KRAS as a druggable target

Politics Bob Herman

STAT Plus: PBMs warn Trump’s proposal to disclose drug prices is illegal

The Readout Meghana Keshavan

STAT Plus: FDA eyes expanding testosterone therapy for libido

Business Tara Bannow

STAT Plus: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions

The Readout Meghana Keshavan

STAT Plus: Cochrane review reignites Alzheimer’s amyloid wars

The Readout Elaine Chen

STAT Plus: Novartis CEO joins Anthropic’s board

The Readout Elaine Chen

STAT Plus: FDA pressures drugmakers to report trial results

Business Tara Bannow

STAT Plus: Federal judge tosses California No Surprises Act lawsuit against HaloMD

Health Care Inc. Newsletter Bob Herman

STAT Plus: Trump goes soft on insurance, and a medical underwriting chart

The Readout Meghana Keshavan

STAT Plus: GSK advancing ovarian cancer drug mo-rez

The Readout Meghana Keshavan

STAT Plus: A new trick for old science, and biotech VCs’ scrambled playbook

Health tech Brittany Trang and John Wilkerson

STAT Plus: Top health officials highlight efforts to make medical records more portable

D.C. Diagnosis John Wilkerson

STAT Plus: A new health care blueprint from a key Democratic think tank

The Readout Meghana Keshavan

STAT Plus: Genetics may shape GLP-1 outcomes, slightly

Politics Bob Herman

STAT Plus: Trump promised to clamp down on health insurers. His policies are enriching them

Business John Wilkerson

STAT Plus: Steve Ubl to step down as CEO of PhRMA

The Readout Elaine Chen

STAT Plus: Terns’ drug may not be as competitive as many initially thought

The Readout Elaine Chen

STAT Plus: Novo Nordisk launches high-dose Wegovy

D.C. Diagnosis John Wilkerson

STAT Plus: Trump budget’s ‘America First’ drug policy proposals

Politics John Wilkerson and Lizzy Lawrence

STAT Plus: FDA backs proposals to entice pharma companies to test, make drugs domestically

Business Bob Herman

STAT Plus: Health insurers score major win with higher 2027 Medicare Advantage rates

Health Care Inc. Newsletter Bob Herman

STAT Plus: A key Medicare Advantage announcement is due today

The Readout Meghana Keshavan

STAT Plus: Stealth biotech Stipple bets on secretive ADCs

The Readout Meghana Keshavan

STAT Plus: Biotech investors’ plea to Trump, and a busy M&A week

Politics Bob Herman

STAT Plus: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures

Biotech Daniel Payne

STAT Plus: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts

The Readout Meghana Keshavan

STAT Plus: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds